Zura Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Cash & Equivalents	99.81	1.57	0.73
Cash & Cash Equivalents	99.81	1.57	0.73
Cash Growth	6269.24%	114.89%	-
Other Current Assets	1.04	0.21	0.42
Total Current Assets	100.84	1.78	1.15
Long-Term Investments	0	0	139.4
Other Long-Term Assets	0	3.49	0
Total Long-Term Assets	0	3.49	139.4
Total Assets	100.84	5.26	140.55
Accounts Payable	20.3	4.43	0.07
Current Debt	0	7.76	0
Other Current Liabilities	0	2.63	0.2
Total Current Liabilities	20.3	14.82	0.27
Other Long-Term Liabilities	0.99	0	10.08
Total Long-Term Liabilities	0.99	0	10.08
Total Liabilities	21.29	14.82	10.35
Total Debt	0	7.76	0
Retained Earnings	-103.49	-32.06	-9.18
Shareholders' Equity	59.33	-32.06	-9.18
Net Cash / Debt	99.81	-6.19	0.73
Net Cash Per Share	3.02	-27.13	0.07
Working Capital	80.54	-13.04	0.88
Book Value Per Share	1.79	-140.50	-0.84

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).